Cita APA

Duncan, C., St. Martin, A., Pérez, W. S., Steinert, P., Zhang, M., Chirnomas, D., . . . Saber, W. (2021). Veno-occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation. Pediatr Blood Cancer.

Citación estilo Chicago

Duncan, Christine, Andrew St. Martin, Waleska S. Pérez, Patricia Steinert, Mei-Jie Zhang, Deborah Chirnomas, Caroline J. Hoang, Fausto R. Loberiza, y Wael Saber. "Veno-occlusive Disease Risk in Pediatric Patients With Acute Myeloid Leukemia Treated With Gemtuzumab Ozogamicin Before Allogeneic Hematopoietic Cell Transplantation." Pediatr Blood Cancer 2021.

Cita MLA

Duncan, Christine, et al. "Veno-occlusive Disease Risk in Pediatric Patients With Acute Myeloid Leukemia Treated With Gemtuzumab Ozogamicin Before Allogeneic Hematopoietic Cell Transplantation." Pediatr Blood Cancer 2021.